Serveur d'exploration sur la COVID en France

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

To immunosuppress: whom, when and how? That is the question with COVID-19.

Identifieur interne : 000354 ( Main/Exploration ); précédent : 000353; suivant : 000355

To immunosuppress: whom, when and how? That is the question with COVID-19.

Auteurs : Kevin L. Winthrop [États-Unis] ; Xavier Mariette [France]

Source :

RBID : pubmed:32753413

Descripteurs français

English descriptors


DOI: 10.1136/annrheumdis-2020-218694
PubMed: 32753413
PubMed Central: PMC7456547


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">To immunosuppress: whom, when and how? That is the question with COVID-19.</title>
<author>
<name sortKey="Winthrop, Kevin L" sort="Winthrop, Kevin L" uniqKey="Winthrop K" first="Kevin L" last="Winthrop">Kevin L. Winthrop</name>
<affiliation wicri:level="2">
<nlm:affiliation>Divisions of Infectious Diseases and Public Health, Oregon Health and Sciences University, Portland, Oregon, USA winthrop@ohsu.edu.</nlm:affiliation>
<country wicri:rule="url">États-Unis</country>
<wicri:regionArea>Divisions of Infectious Diseases and Public Health, Oregon Health and Sciences University, Portland, Oregon</wicri:regionArea>
<placeName>
<region type="state">Oregon</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Mariette, Xavier" sort="Mariette, Xavier" uniqKey="Mariette X" first="Xavier" last="Mariette">Xavier Mariette</name>
<affiliation wicri:level="1">
<nlm:affiliation>Rheumatology, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpitaux Universitaires Paris-Sud, Hôpital Bicêtre, Le Kremlin Bicêtre, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Rheumatology, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpitaux Universitaires Paris-Sud, Hôpital Bicêtre, Le Kremlin Bicêtre</wicri:regionArea>
<wicri:noRegion>Le Kremlin Bicêtre</wicri:noRegion>
<wicri:noRegion>Le Kremlin Bicêtre</wicri:noRegion>
</affiliation>
<affiliation wicri:level="4">
<nlm:affiliation>Université Paris-Sud, Center for Immunology of Viral Infections and Autoimmune Diseases (IMVA), Institut pour la Santé et la Recherche Médicale (INSERM) UMR 1184, Université Paris-Saclay, Le Kremlin Bicêtre, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université Paris-Sud, Center for Immunology of Viral Infections and Autoimmune Diseases (IMVA), Institut pour la Santé et la Recherche Médicale (INSERM) UMR 1184, Université Paris-Saclay, Le Kremlin Bicêtre</wicri:regionArea>
<wicri:noRegion>Le Kremlin Bicêtre</wicri:noRegion>
<orgName type="university">Université Paris-Sud</orgName>
<placeName>
<settlement type="city">Orsay</settlement>
<region type="region" nuts="2">Île-de-France</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32753413</idno>
<idno type="pmid">32753413</idno>
<idno type="doi">10.1136/annrheumdis-2020-218694</idno>
<idno type="pmc">PMC7456547</idno>
<idno type="wicri:Area/Main/Corpus">000728</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000728</idno>
<idno type="wicri:Area/Main/Curation">000728</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000728</idno>
<idno type="wicri:Area/Main/Exploration">000728</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">To immunosuppress: whom, when and how? That is the question with COVID-19.</title>
<author>
<name sortKey="Winthrop, Kevin L" sort="Winthrop, Kevin L" uniqKey="Winthrop K" first="Kevin L" last="Winthrop">Kevin L. Winthrop</name>
<affiliation wicri:level="2">
<nlm:affiliation>Divisions of Infectious Diseases and Public Health, Oregon Health and Sciences University, Portland, Oregon, USA winthrop@ohsu.edu.</nlm:affiliation>
<country wicri:rule="url">États-Unis</country>
<wicri:regionArea>Divisions of Infectious Diseases and Public Health, Oregon Health and Sciences University, Portland, Oregon</wicri:regionArea>
<placeName>
<region type="state">Oregon</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Mariette, Xavier" sort="Mariette, Xavier" uniqKey="Mariette X" first="Xavier" last="Mariette">Xavier Mariette</name>
<affiliation wicri:level="1">
<nlm:affiliation>Rheumatology, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpitaux Universitaires Paris-Sud, Hôpital Bicêtre, Le Kremlin Bicêtre, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Rheumatology, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpitaux Universitaires Paris-Sud, Hôpital Bicêtre, Le Kremlin Bicêtre</wicri:regionArea>
<wicri:noRegion>Le Kremlin Bicêtre</wicri:noRegion>
<wicri:noRegion>Le Kremlin Bicêtre</wicri:noRegion>
</affiliation>
<affiliation wicri:level="4">
<nlm:affiliation>Université Paris-Sud, Center for Immunology of Viral Infections and Autoimmune Diseases (IMVA), Institut pour la Santé et la Recherche Médicale (INSERM) UMR 1184, Université Paris-Saclay, Le Kremlin Bicêtre, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Université Paris-Sud, Center for Immunology of Viral Infections and Autoimmune Diseases (IMVA), Institut pour la Santé et la Recherche Médicale (INSERM) UMR 1184, Université Paris-Saclay, Le Kremlin Bicêtre</wicri:regionArea>
<wicri:noRegion>Le Kremlin Bicêtre</wicri:noRegion>
<orgName type="university">Université Paris-Sud</orgName>
<placeName>
<settlement type="city">Orsay</settlement>
<region type="region" nuts="2">Île-de-France</region>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Annals of the rheumatic diseases</title>
<idno type="eISSN">1468-2060</idno>
<imprint>
<date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Antibodies, Monoclonal, Humanized (MeSH)</term>
<term>Betacoronavirus (MeSH)</term>
<term>Calcinosis (MeSH)</term>
<term>Coronavirus Infections (MeSH)</term>
<term>Cytokines (MeSH)</term>
<term>Glucocorticoids (MeSH)</term>
<term>Heart Valve Diseases (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Hypotrichosis (MeSH)</term>
<term>Pandemics (MeSH)</term>
<term>Pneumonia, Viral (MeSH)</term>
<term>Skin Diseases, Genetic (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Anticorps monoclonaux humanisés (MeSH)</term>
<term>Betacoronavirus (MeSH)</term>
<term>Calcinose (MeSH)</term>
<term>Cytokines (MeSH)</term>
<term>Glucocorticoïdes (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Hypotrichose (MeSH)</term>
<term>Infections à coronavirus (MeSH)</term>
<term>Maladies génétiques de la peau (MeSH)</term>
<term>Pandémies (MeSH)</term>
<term>Pneumopathie virale (MeSH)</term>
<term>Valvulopathies (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en">
<term>Antibodies, Monoclonal, Humanized</term>
<term>Cytokines</term>
<term>Glucocorticoids</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Betacoronavirus</term>
<term>Calcinosis</term>
<term>Coronavirus Infections</term>
<term>Heart Valve Diseases</term>
<term>Humans</term>
<term>Hypotrichosis</term>
<term>Pandemics</term>
<term>Pneumonia, Viral</term>
<term>Skin Diseases, Genetic</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Anticorps monoclonaux humanisés</term>
<term>Betacoronavirus</term>
<term>Calcinose</term>
<term>Cytokines</term>
<term>Glucocorticoïdes</term>
<term>Humains</term>
<term>Hypotrichose</term>
<term>Infections à coronavirus</term>
<term>Maladies génétiques de la peau</term>
<term>Pandémies</term>
<term>Pneumopathie virale</term>
<term>Valvulopathies</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM">
<PMID Version="1">32753413</PMID>
<DateCompleted>
<Year>2020</Year>
<Month>08</Month>
<Day>25</Day>
</DateCompleted>
<DateRevised>
<Year>2020</Year>
<Month>09</Month>
<Day>05</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1468-2060</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>79</Volume>
<Issue>9</Issue>
<PubDate>
<Year>2020</Year>
<Month>09</Month>
</PubDate>
</JournalIssue>
<Title>Annals of the rheumatic diseases</Title>
<ISOAbbreviation>Ann. Rheum. Dis.</ISOAbbreviation>
</Journal>
<ArticleTitle>To immunosuppress: whom, when and how? That is the question with COVID-19.</ArticleTitle>
<Pagination>
<MedlinePgn>1129-1131</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1136/annrheumdis-2020-218694</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Winthrop</LastName>
<ForeName>Kevin L</ForeName>
<Initials>KL</Initials>
<Identifier Source="ORCID">0000-0002-3892-6947</Identifier>
<AffiliationInfo>
<Affiliation>Divisions of Infectious Diseases and Public Health, Oregon Health and Sciences University, Portland, Oregon, USA winthrop@ohsu.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mariette</LastName>
<ForeName>Xavier</ForeName>
<Initials>X</Initials>
<AffiliationInfo>
<Affiliation>Rheumatology, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpitaux Universitaires Paris-Sud, Hôpital Bicêtre, Le Kremlin Bicêtre, France.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Université Paris-Sud, Center for Immunology of Viral Infections and Autoimmune Diseases (IMVA), Institut pour la Santé et la Recherche Médicale (INSERM) UMR 1184, Université Paris-Saclay, Le Kremlin Bicêtre, France.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016421">Editorial</PublicationType>
<PublicationType UI="D016420">Comment</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2020</Year>
<Month>08</Month>
<Day>04</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Ann Rheum Dis</MedlineTA>
<NlmUniqueID>0372355</NlmUniqueID>
<ISSNLinking>0003-4967</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D061067">Antibodies, Monoclonal, Humanized</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D016207">Cytokines</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D005938">Glucocorticoids</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>I031V2H011</RegistryNumber>
<NameOfSubstance UI="C502936">tocilizumab</NameOfSubstance>
</Chemical>
</ChemicalList>
<SupplMeshList>
<SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName>
<SupplMeshName Type="Disease" UI="C566109">Storm Syndrome</SupplMeshName>
<SupplMeshName Type="Organism" UI="C000656484">severe acute respiratory syndrome coronavirus 2</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentOn">
<RefSource>Ann Rheum Dis. 2020 Sep;79(9):1143-1151</RefSource>
<PMID Version="1">32719045</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D061067" MajorTopicYN="N">Antibodies, Monoclonal, Humanized</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002114" MajorTopicYN="N">Calcinosis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018352" MajorTopicYN="Y">Coronavirus Infections</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016207" MajorTopicYN="Y">Cytokines</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005938" MajorTopicYN="Y">Glucocorticoids</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006349" MajorTopicYN="N">Heart Valve Diseases</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007039" MajorTopicYN="N">Hypotrichosis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D058873" MajorTopicYN="Y">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011024" MajorTopicYN="Y">Pneumonia, Viral</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012873" MajorTopicYN="N">Skin Diseases, Genetic</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="Y">arthritis</Keyword>
<Keyword MajorTopicYN="Y">biological therapy</Keyword>
<Keyword MajorTopicYN="Y">glucocorticoids</Keyword>
<Keyword MajorTopicYN="Y">rheumatoid</Keyword>
</KeywordList>
<CoiStatement>Competing interests: KLW reports personal fees from Pfizer, AbbVie, Union Chimique Belge (UCB), Eli Lilly & Company, Galapagos, GlaxoSmithKline (GSK), Roche, and Gilead and reports research grants from BMS, Pfizer, outside the submitted work.</CoiStatement>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2020</Year>
<Month>07</Month>
<Day>24</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2020</Year>
<Month>07</Month>
<Day>29</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2020</Year>
<Month>07</Month>
<Day>29</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2020</Year>
<Month>8</Month>
<Day>6</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2020</Year>
<Month>8</Month>
<Day>26</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2020</Year>
<Month>8</Month>
<Day>6</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">32753413</ArticleId>
<ArticleId IdType="pii">annrheumdis-2020-218694</ArticleId>
<ArticleId IdType="doi">10.1136/annrheumdis-2020-218694</ArticleId>
<ArticleId IdType="pmc">PMC7456547</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>J Clin Virol. 2004 Dec;31(4):304-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15494274</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Intensive Care Med. 2018 Sep;44(9):1470-1482</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30074052</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Intern Med. 2020 Jun 30;:</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32603493</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Shock. 2020 Jun 02;:</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32496422</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Chest. 2020 Jun 15;:</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32553536</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Rheum Dis. 2020 Jun 10;:</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32522741</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA Intern Med. 2020 Mar 13;:</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32167524</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet Rheumatol. 2020 Aug;2(8):e474-e484</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32835257</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Gastroenterology. 2020 Aug;159(2):481-491.e3</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32425234</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2020 Jun 23;:</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32575124</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Rheum Dis. 2020 May;79(5):573-580</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32209540</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>QJM. 2020 Aug 1;113(8):546-550</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32569363</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Respir Crit Care Med. 2018 Mar 15;197(6):757-767</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29161116</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2020 Jul 11;:</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32651997</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Rheum Dis. 2020 Jul 9;:</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32647027</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Thorax. 2004 May;59(5):414-20</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15115870</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Diabetes Metab Syndr. 2020 Jun 27;14(5):971-978</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32610262</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Rheumatology (Oxford). 2019 May 1;58(5):849-858</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30590833</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2020 May 19;117(20):10970-10975</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32350134</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Antimicrob Agents. 2020 Aug;56(2):106077</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32634602</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Rheum Dis. 2020 Sep;79(9):1143-1151</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32719045</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur J Intern Med. 2020 Jun;76:43-49</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32482597</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2020 Jul 17;:</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32678530</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Gastroenterol Hepatol. 2020 Jun 20;:</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32569749</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>France</li>
<li>États-Unis</li>
</country>
<region>
<li>Oregon</li>
<li>Île-de-France</li>
</region>
<settlement>
<li>Orsay</li>
</settlement>
<orgName>
<li>Université Paris-Sud</li>
</orgName>
</list>
<tree>
<country name="États-Unis">
<region name="Oregon">
<name sortKey="Winthrop, Kevin L" sort="Winthrop, Kevin L" uniqKey="Winthrop K" first="Kevin L" last="Winthrop">Kevin L. Winthrop</name>
</region>
</country>
<country name="France">
<noRegion>
<name sortKey="Mariette, Xavier" sort="Mariette, Xavier" uniqKey="Mariette X" first="Xavier" last="Mariette">Xavier Mariette</name>
</noRegion>
<name sortKey="Mariette, Xavier" sort="Mariette, Xavier" uniqKey="Mariette X" first="Xavier" last="Mariette">Xavier Mariette</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000354 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000354 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:32753413
   |texte=   To immunosuppress: whom, when and how? That is the question with COVID-19.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:32753413" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidFranceV1 

Wicri

This area was generated with Dilib version V0.6.37.
Data generation: Tue Oct 6 23:31:36 2020. Site generation: Fri Feb 12 22:48:37 2021